|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,086.00 GBX | -8.10% |
|
-10.61% | -5.76% |
| 09:34am | Ionis, AstraZeneca Report Amyloid Cardiomyopathy Treatment Failed to Meet Primary Endpoint in Phase 3 | MT |
| 09:30am | AstraZeneca shares slump after clinical trial fails |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTRAZENECA PLC | Other Pharmaceuticals | -8.71% | -10.61% | -5.76% | +25.42% | +50.28% | 295B |  |  | |
- Stock Market
- Stocks
- AZN Stock
- Charts AstraZeneca PLC
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
